These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23388656)

  • 1. Synthesis of selective inhibitors of sphingosine kinase 1.
    Baek DJ; MacRitchie N; Pyne NJ; Pyne S; Bittman R
    Chem Commun (Camb); 2013 Mar; 49(21):2136-8. PubMed ID: 23388656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
    Tonelli F; Lim KG; Loveridge C; Long J; Pitson SM; Tigyi G; Bittman R; Pyne S; Pyne NJ
    Cell Signal; 2010 Oct; 22(10):1536-42. PubMed ID: 20570726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
    Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
    J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alkyl chain length on sphingosine kinase 2 selectivity.
    Knott K; Kharel Y; Raje MR; Lynch KR; Santos WL
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6817-20. PubMed ID: 22321213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.
    Raje MR; Knott K; Kharel Y; Bissel P; Lynch KR; Santos WL
    Bioorg Med Chem; 2012 Jan; 20(1):183-94. PubMed ID: 22137932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism.
    Tonelli F; Alossaimi M; Williamson L; Tate RJ; Watson DG; Chan E; Bittman R; Pyne NJ; Pyne S
    Br J Pharmacol; 2013 Mar; 168(6):1497-505. PubMed ID: 23113536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel sphingosine kinase 1 inhibitors.
    Xiang Y; Asmussen G; Booker M; Hirth B; Kane JL; Liao J; Noson KD; Yee C
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6119-21. PubMed ID: 19800228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase.
    Spijkers LJ; Alewijnse AE; Peters SL
    Br J Pharmacol; 2012 Jun; 166(4):1411-8. PubMed ID: 22251137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
    Lee JW; Ryu JY; Yoon G; Jeon HK; Cho YJ; Choi JJ; Song SY; Do IG; Lee YY; Kim TJ; Choi CH; Kim BG; Bae DS
    Int J Cancer; 2015 Jul; 137(1):221-9. PubMed ID: 25429856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension.
    MacRitchie N; Volpert G; Al Washih M; Watson DG; Futerman AH; Kennedy S; Pyne S; Pyne NJ
    Cell Signal; 2016 Aug; 28(8):946-55. PubMed ID: 27063355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart.
    Vessey DA; Kelley M; Zhang J; Li L; Tao R; Karliner JS
    J Biochem Mol Toxicol; 2007; 21(5):273-9. PubMed ID: 17912702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.
    Pchejetski D; Böhler T; Stebbing J; Waxman J
    Nat Rev Urol; 2011 Sep; 8(10):569-678. PubMed ID: 21912422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors.
    Baek DJ; MacRitchie N; Anthony NG; Mackay SP; Pyne S; Pyne NJ; Bittman R
    J Med Chem; 2013 Nov; 56(22):9310-27. PubMed ID: 24164513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases.
    Adams DR; Pyne S; Pyne NJ
    Cell Signal; 2020 Dec; 76():109806. PubMed ID: 33035646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules.
    Pyne S; Bittman R; Pyne NJ
    Cancer Res; 2011 Nov; 71(21):6576-82. PubMed ID: 21940750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kelch-like protein 5-mediated ubiquitination of lysine 183 promotes proteasomal degradation of sphingosine kinase 1.
    Powell JA; Pitman MR; Zebol JR; Moretti PAB; Neubauer HA; Davies LT; Lewis AC; Dagley LF; Webb AI; Costabile M; Pitson SM
    Biochem J; 2019 Nov; 476(21):3211-3226. PubMed ID: 31652307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.
    Loveridge C; Tonelli F; Leclercq T; Lim KG; Long JS; Berdyshev E; Tate RJ; Natarajan V; Pitson SM; Pyne NJ; Pyne S
    J Biol Chem; 2010 Dec; 285(50):38841-52. PubMed ID: 20926375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics.
    Evangelisti C; Evangelisti C; Teti G; Chiarini F; Falconi M; Melchionda F; Pession A; Bertaina A; Locatelli F; McCubrey JA; Beak DJ; Bittman R; Pyne S; Pyne NJ; Martelli AM
    Oncotarget; 2014 Sep; 5(17):7886-901. PubMed ID: 25226616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues.
    Högenauer K; Billich A; Pally C; Streiff M; Wagner T; Welzenbach K; Nussbaumer P
    ChemMedChem; 2008 Jul; 3(7):1027-9. PubMed ID: 18383466
    [No Abstract]   [Full Text] [Related]  

  • 20. (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells.
    Lim KG; Sun C; Bittman R; Pyne NJ; Pyne S
    Cell Signal; 2011 Oct; 23(10):1590-5. PubMed ID: 21620961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.